Trending News
News
News
Trinean Secures 1 Million Euro Financing
Capricorn Health-tech Fund to join the investor base.
News
Researchers Identify Novel Class of Drugs for Prostate Cancers
A new study on prostate cancer describes a novel class of drugs that interrupts critical signaling needed for prostate cancer cells to grow.
News
Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion
Valeant will finance the transaction with debt and approximately $1.5 - $2.0 billion of new equity.
News
Cobra Biologics and Recopharma Enter Agreement
Agreement to utilize Cobra’s cell line development service- MaxXpress.
News
Leatherhead Opens DirtyLab
Leatherhead’s Food Safety Day saw the official opening of its Pathogen Pilot Plant, DirtyLab, a new facility for pathogen challenge testing.
News
Hepregen Announces Issuance of its First Patent
The patent protects manufacturing methods of Hepatopac and related products.
News
Encouraging Data from Stem Cell Trial in Stroke Patients as Plans for Phase II Progress
Encouraging interim data from the world’s first clinical trial examining the safety of neural stem cell treatment in stroke patients has been reported by researchers ahead of an application for Phase II trials.
News
Imaging Biomarker Predicts Response to Rapid Antidepressant
A telltale boost of activity at the back of the brain while processing emotional information predicted depressed patients’ response to experimental antidepressant.
News
Insight into the Dazzling Impact of Insulin in Cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before.
News
Awoken from a Persistent Vegetative State
First successful treatment of paediatric cerebral palsy with autologous cord blood.
Advertisement